keyword
https://read.qxmd.com/read/38651188/potential-utility-of-pretreatment-serum-mirnas-for-optimal-treatment-selection-in-advanced-high-grade-serous-ovarian-cancer
#1
JOURNAL ARTICLE
Takashi Uehara, Juntaro Matsuzaki, Hiroshi Yoshida, Yuto Ogawa, Junichiro Miura, Hitoshi Fujimiya, Yusuke Yamamoto, Junpei Kawauchi, Satoko Takizawa, Kan Yonemori, Hiromi Sakamoto, Ken Kato, Mitsuya Ishikawa, Takahiro Ochiya
OBJECTIVE: The primary treatment of patients with advanced ovarian cancer is selected from whether primary debulking surgery or neoadjuvant chemotherapy. We investigated whether pretreatment serum microRNA profiles are useful for selecting patients with advanced high-grade serous ovarian cancer who obtain better outcomes from undergoing primary debulking surgery or neoadjuvant chemotherapy. METHODS: Consecutive patients with clinical stage IIIB-IVB and serum microRNA data were selected...
April 22, 2024: Japanese Journal of Clinical Oncology
https://read.qxmd.com/read/38647435/correction-for-inhibition-of-circulating-exosomal-microrna-15a-3p-accelerates-diabetic-wound-repair
#2
JOURNAL ARTICLE
Yuan Xiong, Lang Chen, Tao Yu, Chenchen Yan, Wu Zhou, Faqi Cao, Xiaomeng You, Yingqi Zhang, Yun Sun, Jing Liu, Hang Xue, Yiqiang Hu, Dong Chen, Bobin Mi, Guohui Liu
No abstract text is available yet for this article.
April 15, 2024: Aging
https://read.qxmd.com/read/38645356/brca-mutations-and-microrna-expression-patterns-in-the-peripheral-blood-of-breast-cancer-patients
#3
JOURNAL ARTICLE
Ceren Alavanda, Esra Dirimtekin, Maria Mortoglou, Esra Arslan Ates, Ahmet Ilter Guney, Pinar Uysal-Onganer
Breast cancer (BC) persists as the predominant malignancy globally, standing as the foremost cause of cancer-related mortality among women. Despite notable advancements in prevention and treatment, encompassing the incorporation of targeted immunotherapies, a continued imperative exists for the development of innovative methodologies. These methodologies would facilitate the identification of women at heightened risk, enhance the optimization of therapeutic approaches, and enable the vigilant monitoring of emergent treatment resistance...
April 16, 2024: ACS Omega
https://read.qxmd.com/read/38645053/profiling-microrna-expression-during-senescence-and-aging-mining-for-a-diagnostic-tool-of-senescent-cell-burden
#4
Moritz Weigl, Teresa L Krammer, Marianne Pultar, Matthias Wieser, Selim Chaib, Masayoshi Suda, Andreas Diendorfer, Kseniya Khamina-Kotisch, Nino Giorgadze, Tamar Pirtskhalava, Kurt O Johnson, Christina L Inman, Ailing Xue, Ingo Lämmermann, Barbara Meixner, Lichao Wang, Ming Xu, Regina Grillari, Mikolaj Ogrodnik, Tamar Tchkonia, Matthias Hackl, James L Kirkland, Johannes Grillari
In the last decade cellular senescence, a hallmark of aging, has come into focus for pharmacologically targeting aging processes. Senolytics are one of these interventive strategies that have advanced into clinical trials, creating an unmet need for minimally invasive biomarkers of senescent cell load to identify patients at need for senotherapy. We created a landscape of miRNA and mRNA expression in five human cell types induced to senescence in-vitro and provide proof-of-principle evidence that miRNA expression can track senescence burden dynamically in-vivo using transgenic p21 high senescent cell clearance in HFD fed mice...
April 10, 2024: bioRxiv
https://read.qxmd.com/read/38638083/circulating-mirna-in-functional-tricuspid-regurgitation-unveiling-novel-links-to-heart-failure-a-pilot-study
#5
JOURNAL ARTICLE
Rocio Hinojar, Rafael Moreno-Gómez-Toledano, Elisa Conde, Ariana Gonzalez-Gomez, Ana García-Martin, Paz González-Portilla, Covadonga Fernández-Golfín, Maria Laura García-Bermejo, Carlos Zaragoza, Jose Luis Zamorano
AIM: Severe functional tricuspid regurgitation (FTR) is associated with high risk of cardiovascular events, particularly heart failure (HF) and mortality. MicroRNAs (miRNAs) have been recently identified as novel biomarkers in different cardiovascular conditions, but no studies have focused on FTR. We sought to (1) to identify and validate circulating miRNAs as regulators of FTR and (2) to test association of miRNA with heart failure and mortality in FTR. METHODS AND RESULTS: Consecutive patients with isolated severe FTR (n = 100) evaluated in the outpatient Heart Valve Clinic and age- and gender-matched subjects with no TR (controls, n = 50) were prospectively recruited...
April 18, 2024: ESC Heart Failure
https://read.qxmd.com/read/38632655/schwann-cell-derived-extracellular-vesicles-promote-memory-impairment-associated-with-chronic-neuropathic-pain
#6
JOURNAL ARTICLE
Yidan Tang, Jiahui Wu, Changliang Liu, Lu Gan, Hai Chen, Ya-Lan Sun, Jin Liu, Yuan-Xiang Tao, Tao Zhu, Chan Chen
BACKGROUND: The pathogenesis of memory impairment, a common complication of chronic neuropathic pain (CNP), has not been fully elucidated. Schwann cell (SC)-derived extracellular vesicles (EVs) contribute to remote organ injury. Here, we showed that SC-EVs may mediate pathological communication between SCs and hippocampal neurons in the context of CNP. METHODS: We used an adeno-associated virus harboring the SC-specific promoter Mpz and expressing the CD63-GFP gene to track SC-EVs transport...
April 17, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38628314/microrna-analysis-of-medium-large-placenta-extracellular-vesicles-in-normal-and-preeclampsia-pregnancies
#7
JOURNAL ARTICLE
Toluwalase Awoyemi, Shuhan Jiang, Maryam Rahbar, Prasanna Logentherian, Gavin Collett, Wei Zhang, Adam Cribbs, Sofia Cerdeira, Manu Vatish
BACKGROUND: Preeclampsia (PE) is a hypertensive disorder of pregnancy, affecting 2%-8% of pregnancies worldwide, and is the leading cause of adverse maternal and fetal outcomes. The disease is characterized by oxidative and cellular stress and widespread endothelial dysfunction. While the precise mechanisms are not entirely understood, the pathogenesis of PE is closely linked to placental dysfunction and, to some extent, syncytiotrophoblast extracellular vesicle release (STB-EVs). These vesicles can be divided into the less well-studied medium/large EVs (220-1,000 nm) released in response to stress and small EVs (<220 nm) released as a component of intercellular communication...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38623975/early-detection-precision-treatment-recurrence-monitoring-liquid-biopsy-transforms-colorectal-cancer-therapy
#8
JOURNAL ARTICLE
Harshvardhan Raval, Sankha Bhattacharya
Colorectal cancer (CRC) is a significant global health concern. We need ways to detect it early and determine the best treatments. One promising method is liquid biopsy, which uses cancer cells and other components in the blood to help diagnose and treat the disease. Liquid biopsies focus on three key elements: circulating tumor DNA (ctDNA), circulating microRNA (miRNA), and circulating tumor cells (CTC). By analyzing these elements, we can identify CRC in its early stages, predict how well a treatment will work, and even spot signs of cancer returning...
April 15, 2024: Current Cancer Drug Targets
https://read.qxmd.com/read/38622570/a-systematic-review-and-meta-analysis-of-circulating-serum-and-plasma-micrornas-in-tb-diagnosis
#9
JOURNAL ARTICLE
Harinisri Gunasekaran, Pavithra Sampath, Kannan Thiruvengadam, Muniyandi Malaisamy, Rathinasabapati Ramasamy, Uma Devi Ranganathan, Ramalingam Bethunaickan
BACKGROUND: Tuberculosis (TB) ranks as the second leading cause of death globally among all infectious diseases. This problem is likely due to the lack of biomarkers to differentiate the heterogeneous spectrum of infection. Therefore, the first step in solving this problem is to identify biomarkers to distinguish the different disease states of an individual and treat them accordingly. Circulating microRNA (miRNA) biomarkers are promising candidates for various diseases. In fact, we are yet to conceptualize how miRNA expression influences and predicts TB disease outcomes...
April 15, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38619629/identification-of-a-circulating-three-mirna-panel-for-the-diagnosis-of-primary-open-angle-glaucoma
#10
JOURNAL ARTICLE
Bo Qin, Li-Ping Li, Qing-Dan Xu, Yuan Lei, Yu-Hong Chen
PURPOSE: Conventional diagnosis of primary open angle glaucoma (POAG) needs a combination of ophthalmic examinations. An efficient assay is urgently needed for a timely POAG diagnosis. We aim to explore differential expressions of circulating microRNAs (miRNA) and provide novel miRNA biomarkers for POAG diagnosis. METHODS: A total of 180 POAG patients and 210 age-related cataract (ARC) patients were enrolled. We collected aqueous humor (AH) and plasma samples from the recruited patients...
April 15, 2024: International Ophthalmology
https://read.qxmd.com/read/38618258/circulating-levels-of-hotair-lncrna-are-associated-with-disease-progression-and-clinical-parameters-in-type-2-diabetes-patients
#11
JOURNAL ARTICLE
Nafiseh Niknam, Shekoofeh Nikooei, Hassan Ghasemi, Seyed Sajjad Zadian, Kamran Goudarzi, Seyed Majid Ahmadi, Behnam Alipoor
BACKGROUND: Recent studies have implicated dysregulated long non-coding RNA (lncRNA) levels in the pathogenesis of type 2 diabetes (T2D). This study aimed to assess the expression of circulating HOTAIR and uc.48+, examining their correlation with clinical and biochemical variables in T2D patients, pre-diabetic individuals, and healthy controls. METHODS: Peripheral blood levels of lncRNAs were quantified using QRT-PCR in 65 T2D patients, 63 pre-diabetic individuals, and 63 healthy subjects...
October 2023: Reports of Biochemistry & Molecular Biology
https://read.qxmd.com/read/38615267/serum-microrna-16-as-a-potential-biomarker-for-hcv-induced-hepato-cellular-carcinoma-in-egyptian-patients
#12
JOURNAL ARTICLE
Amr T El Hawary, Fedaa Nabil, Ramy El Hendawy, Haytham K A Mahrous, Ghada A AbdelHamid, Mahmoud Amer
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers in the world. Two risk factors that cause 80-90% of HCC cases globally are chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). The diagnostic value of circulating microRNAs (miRNAs) in numerous tumors has been described. Our research assessed microRNA-16 (miR-16) as a novel biomarker in patients with HCV-induced HCC. The study included three groups. Group 1 included 55 individuals with cirrhosis caused by liver HCV infection in addition to HCC...
April 2024: Egyptian Journal of Immunology
https://read.qxmd.com/read/38615118/circulating-microrna-155-3p-levels-predicts-response-to-first-line-immunotherapy-in-patients-with-metastatic-renal-cell-carcinoma
#13
JOURNAL ARTICLE
Maryam Soleimani, Marisa Thi, Sajjad Janfaza, Gizem Ozcan, Sylwia Mazurek, Guliz Ozgun, Corinne Maurice-Dror, Bernhard Eigl, Kim Chi, Christian Kollmannsberger, Lucia Nappi
Predictive biomarkers of response to immune checkpoint-based therapies (ICI) remain a critically unmet need in the management of advanced renal cell carcinoma (RCC). The complex interplay of the tumour microenvironment (TME) and the circulating immune response has proven to be challenging to decipher. MicroRNAs have gained increasing attention for their role in post-transcriptional gene expression regulation, particularly because they can have immunomodulatory properties. We evaluated the presence of immune-specific extracellular vesicle (EV) microRNAs in the plasma of patients with metastatic RCC (mRCC) prior to initiation of ICI...
April 13, 2024: Scientific Reports
https://read.qxmd.com/read/38612727/micrornas-in-pancreatic-cancer-advances-in-biomarker-discovery-and-therapeutic-implications
#14
REVIEW
Roland Madadjim, Thuy An, Juan Cui
Pancreatic cancer remains a formidable malignancy characterized by high mortality rates, primarily attributable to late-stage diagnosis and a dearth of effective therapeutic interventions. The identification of reliable biomarkers holds paramount importance in enhancing early detection, prognostic evaluation, and targeted treatment modalities. Small non-coding RNAs, particularly microRNAs, have emerged as promising candidates for pancreatic cancer biomarkers in recent years. In this review, we delve into the evolving role of cellular and circulating miRNAs, including exosomal miRNAs, in the diagnosis, prognosis, and therapeutic targeting of pancreatic cancer...
March 31, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38612677/unlocking-precision-medicine-liquid-biopsy-advancements-in-renal-cancer-detection-and-monitoring
#15
REVIEW
Felice Crocetto, Alfonso Falcone, Benito Fabio Mirto, Enrico Sicignano, Giovanni Pagano, Fabrizio Dinacci, Domenico Varriale, Fabio Machiella, Gaetano Giampaglia, Armando Calogero, Filippo Varlese, Raffaele Balsamo, Francesco Trama, Antonella Sciarra, Francesco Del Giudice, Gian Maria Busetto, Matteo Ferro, Giuseppe Lucarelli, Francesco Lasorsa, Ciro Imbimbo, Biagio Barone
Renal cell carcinoma (RCC) remains a formidable diagnostic challenge, especially in the context of small renal masses. The quest for non-invasive screening tools and biomarkers has steered research towards liquid biopsy, focusing on microRNAs (miRNAs), exosomes, and circulating tumor cells (CTCs). MiRNAs, small non-coding RNAs, exhibit notable dysregulation in RCC, offering promising avenues for diagnosis and prognosis. Studies underscore their potential across various biofluids, including plasma, serum, and urine, for RCC detection and subtype characterization...
March 30, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611057/advancing-gct-management-a-review-of-mir-371a-3p-and-other-mirnas-in-comparison-to-traditional-serum-tumor-markers
#16
REVIEW
Crystal L Seales, Dhruv Puri, Nuphat Yodkhunnatham, Kshitij Pandit, Kit Yuen, Sarah Murray, Jane Smitham, John T Lafin, Aditya Bagrodia
MicroRNAs, short non-protein coding RNAs, are overexpressed in GCTs. Circulating levels of germ cell tumor (GCT)-associated miRNAs, such as miR-371a-3p, can be utilized as efficient and cost-effective alternatives in diagnosing and managing patients presenting with GCTs. This quality of miRNAs has demonstrated favorable performance characteristics as a reliable blood-based biomarker with high diagnostic accuracy compared to current serum tumor markers (STMs), including α-fetoprotein (AFP), beta human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH)...
March 31, 2024: Cancers
https://read.qxmd.com/read/38611042/prediction-of-response-to-anti-angiogenic-treatment-for-advanced-colorectal-cancer-patients-from-biological-factors-to-functional-imaging
#17
REVIEW
Giuseppe Corrias, Eleonora Lai, Pina Ziranu, Stefano Mariani, Clelia Donisi, Nicole Liscia, Giorgio Saba, Andrea Pretta, Mara Persano, Daniela Fanni, Dario Spanu, Francesca Balconi, Francesco Loi, Simona Deidda, Angelo Restivo, Valeria Pusceddu, Marco Puzzoni, Cinzia Solinas, Elena Massa, Clelia Madeddu, Clara Gerosa, Luigi Zorcolo, Gavino Faa, Luca Saba, Mario Scartozzi
Colorectal cancer (CRC) is a leading tumor worldwide. In CRC, the angiogenic pathway plays a crucial role in cancer development and the process of metastasis. Thus, anti-angiogenic drugs represent a milestone for metastatic CRC (mCRC) treatment and lead to significant improvement of clinical outcomes. Nevertheless, not all patients respond to treatment and some develop resistance. Therefore, the identification of predictive factors able to predict response to angiogenesis pathway blockade is required in order to identify the best candidates to receive these agents...
March 30, 2024: Cancers
https://read.qxmd.com/read/38608766/exosomal-mir-1202-mediates-brodmann-area-44-functional-connectivity-changes-in-medication-free-patients-with-major-depressive-disorder-an-fmri-study
#18
JOURNAL ARTICLE
Shuguang Han, Qingtong Zheng, Zixuan Zheng, Jie Su, Xiaohua Liu, Changzhou Shi, Bo Li, Xuanxuan Zhang, Minghao Zhang, Qian Yu, Ziwei Hou, Ting Li, Bin Zhang, Yong Lin, Ge Wen, Yanjia Deng, Kai Liu, Kai Xu
Previous large-sample postmortem study revealed that the expression of miR-1202 in brain tissues from Brodmann area 44 (BA44) was dysregulated in patients with major depressive disorder (MDDs). However, the specific in vivo neuropathological mechanism of miR-1202 as well as its interplay with BA44 circuits in the depressed brain are still unclear. Here, we performed a case-control study with imaging-genetic approach based on resting-state functional magnetic resonance imaging (MRI) data and miR-1202 quantification from 110 medication-free MDDs and 102 healthy controls...
April 10, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38607678/fibromyalgia-one-year-in-review-2024
#19
REVIEW
Marco Di Carlo, Benedetta Bianchi, Fausto Salaffi, Greta Pellegrino, Cristina Iannuccelli, Valeria Giorgi, Piercarlo Sarzi-Puttini
Fibromyalgia (FM) remains a condition with a pathogenesis that is not completely understood, affecting a significant portion of the global population. This article summarises the main advances in FM during the last year. Even in 2023, research on FM was notably active. From a clinimetric perspective, studies have been conducted to evaluate the possibilities of interchanging the primary indices of disease severity, primarily for studies with substantial case numbers. Regarding FM pathogenesis, ongoing research focuses on small fiber neuropathy: some studies have documented its association with central sensitisation, while others have revealed distinct sensory profiles in patients with FM and small fiber neuropathy compared to those solely with small fiber neuropathy...
April 10, 2024: Clinical and Experimental Rheumatology
https://read.qxmd.com/read/38606148/week-by-week-changes-in-serum-levels-of-bone-related-circulating-micrornas-and-bone-turnover-markers
#20
JOURNAL ARTICLE
Patryk Zarecki, Fatma Gossiel, Johannes Grillari, Miguel Debono, Matthias Hackl, Richard Eastell
MicroRNAs are involved in post-transcriptional regulation of gene expression. Due to their regulatory role, microRNAs are differently expressed during specific conditions in healthy and diseased individuals, so microRNAs circulating in the blood could be used as diagnostic and prognostic biomarkers for various diseases and conditions. We want to investigate the variability of circulating microRNAs and bone turnover markers in weekly time intervals in older women. In a single-site longitudinal study, a panel of 19 bone-related miRNAs was measured using the osteomiR RT-qPCR assay in serum samples of 35 postmenopausal women divided into 3 groups: healthy controls ( n  = 12), low BMD ( n  = 14), and vertebral fractures ( n  = 9)...
May 2024: JBMR Plus
keyword
keyword
162752
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.